Bioequivalence assessment of two formulations of ibuprofen

BACKGROUND: This study assessed the relative bioavailability of two formulations of ibuprofen. The first formulation was Doloraz(®), produced by Al-Razi Pharmaceutical Company, Amman, Jordan. The second forumulation was Brufen(®), manufactured by Boots Company, Nottingham, UK. METHODS AND RESULTS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Talla, Zeyad A, Akrawi, Sabah H, Tolley, Luke T, Sioud, Salim H, Zaater, Mohammed F, Emwas, Abdul-Hamid M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210071/
https://www.ncbi.nlm.nih.gov/pubmed/22087062
http://dx.doi.org/10.2147/DDDT.S24504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210071/
https://www.ncbi.nlm.nih.gov/pubmed/22087062
http://dx.doi.org/10.2147/DDDT.S24504

Ejemplares similares